Relationship Between the Japanese Version of the Montreal Cognitive Assessment and PET Imaging in Subjects with Mild Cognitive Impairment.

18F-fluorodeoxyglucose-positron emission tomography Amyloid positron emission tomography Brain regions Japanese version of the Montreal Cognitive Assessment Mild cognitive impairment prospective study.

Journal

Current Alzheimer research
ISSN: 1875-5828
Titre abrégé: Curr Alzheimer Res
Pays: United Arab Emirates
ID NLM: 101208441

Informations de publication

Date de publication:
2019
Historique:
received: 08 02 2019
revised: 28 05 2019
accepted: 23 07 2019
pubmed: 7 8 2019
medline: 4 9 2020
entrez: 7 8 2019
Statut: ppublish

Résumé

The Montreal Cognitive Assessment (MoCA) test has high sensitivity and specificity for detecting mild cognitive impairment or early dementia. How the MoCA score relates to findings of positron emission tomography imaging, however, remains unclear. This prospective study examined the relationship between the Japanese version of the MoCA (MoCA-J) test and brain amyloid deposition or cerebral glucose metabolism among subjects with mild cognitive impairment. A total of 125 subjects with mild cognitive impairment underwent the MoCA-J test, and amyloid- and 18F-fluorodeoxyglucose- positron emission tomography. Linear correlation analysis and multiple linear regression analysis were conducted to investigate the relationship between the MoCA-J score and demographic characteristics, amyloid deposition, and cerebral glucose metabolism. Moreover, Statistical Parametric Mapping 8 was used for a voxel-wise regression analysis of the MoCA-J score and cerebral glucose metabolism. The MoCA-J score significantly correlated with age, years of education, and the Mini-Mental State Examination score. After adjusting for age, sex, and education, the MoCA-J score significantly correlated negatively with amyloid retention (β= -0.174, p= 0.031) and positively with cerebral glucose metabolism (β= 0.183, p= 0.044). Statistical Parametric Mapping showed that Japanese version of MoCA score correlated with glucose metabolism in the bilateral frontal and parietal lobes, and the left precuneus. The total MoCA-J score correlated with amyloid deposition and frontal and parietal glucose metabolism in subjects with mild cognitive impairment. Our findings support the usefulness of the MoCA-J test for screening subjects at high risk for Alzheimer's disease.

Sections du résumé

BACKGROUND
The Montreal Cognitive Assessment (MoCA) test has high sensitivity and specificity for detecting mild cognitive impairment or early dementia. How the MoCA score relates to findings of positron emission tomography imaging, however, remains unclear.
OBJECTIVE
This prospective study examined the relationship between the Japanese version of the MoCA (MoCA-J) test and brain amyloid deposition or cerebral glucose metabolism among subjects with mild cognitive impairment.
METHODS
A total of 125 subjects with mild cognitive impairment underwent the MoCA-J test, and amyloid- and 18F-fluorodeoxyglucose- positron emission tomography. Linear correlation analysis and multiple linear regression analysis were conducted to investigate the relationship between the MoCA-J score and demographic characteristics, amyloid deposition, and cerebral glucose metabolism. Moreover, Statistical Parametric Mapping 8 was used for a voxel-wise regression analysis of the MoCA-J score and cerebral glucose metabolism.
RESULTS
The MoCA-J score significantly correlated with age, years of education, and the Mini-Mental State Examination score. After adjusting for age, sex, and education, the MoCA-J score significantly correlated negatively with amyloid retention (β= -0.174, p= 0.031) and positively with cerebral glucose metabolism (β= 0.183, p= 0.044). Statistical Parametric Mapping showed that Japanese version of MoCA score correlated with glucose metabolism in the bilateral frontal and parietal lobes, and the left precuneus.
CONCLUSION
The total MoCA-J score correlated with amyloid deposition and frontal and parietal glucose metabolism in subjects with mild cognitive impairment. Our findings support the usefulness of the MoCA-J test for screening subjects at high risk for Alzheimer's disease.

Identifiants

pubmed: 31385770
pii: CAR-EPUB-100134
doi: 10.2174/1567205016666190805155230
doi:

Substances chimiques

Amyloid 0
Radiopharmaceuticals 0
Fluorodeoxyglucose F18 0Z5B2CJX4D
Glucose IY9XDZ35W2

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

852-860

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Atsuko Eguchi (A)

Department of Neurology, Faculty of Medicine, Oita University, Yufu, Oita 879-5593, Japan.

Noriyuki Kimura (N)

Department of Neurology, Faculty of Medicine, Oita University, Yufu, Oita 879-5593, Japan.

Yasuhiro Aso (Y)

Department of Neurology, Faculty of Medicine, Oita University, Yufu, Oita 879-5593, Japan.

Kenichi Yabuuchi (K)

Department of Neurology, Faculty of Medicine, Oita University, Yufu, Oita 879-5593, Japan.

Masato Ishibashi (M)

Department of Neurology, Faculty of Medicine, Oita University, Yufu, Oita 879-5593, Japan.

Daiji Hori (D)

Department of Neurology, Faculty of Medicine, Oita University, Yufu, Oita 879-5593, Japan.

Yuuki Sasaki (Y)

Department of Neurology, Faculty of Medicine, Oita University, Yufu, Oita 879-5593, Japan.

Atsuhito Nakamichi (A)

Department of Neurology, Faculty of Medicine, Oita University, Yufu, Oita 879-5593, Japan.

Souhei Uesugi (S)

Department of Neurology, Faculty of Medicine, Oita University, Yufu, Oita 879-5593, Japan.

Mika Jikumaru (M)

Department of Neurology, Faculty of Medicine, Oita University, Yufu, Oita 879-5593, Japan.

Kaori Sumi (K)

Department of Neurology, Faculty of Medicine, Oita University, Yufu, Oita 879-5593, Japan.

Tsuyoshi Shimomura (T)

Department of Neurosurgery, Oita University, Faculty of Medicine, Yufu, Oita 879-5593, Japan.

Etsuro Matsubara (E)

Department of Neurology, Faculty of Medicine, Oita University, Yufu, Oita 879-5593, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH